CrossrefInfokarte
[Retracted] Bone morphogenetic protein and activin membrane‑bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF‑β‑induced EMT signaling pathway
Oncology Letters · 2026-11-09 · 33 (1) · 1-1
DOI: 10.3892/ol.2026.15941 ↗Abstract
Kein Abstract verfügbar.
EUVIMED